Form 4: Perspective Therapeutics CFO Juan Graham Acquires Shares

Juan Graham, CFO of Perspective Therapeutics, recently purchased 33,333 shares of the company's common stock at an average price of $2.2484 per share.

Summary

• On March 28, 2025, Juan Graham, the Chief Financial Officer of Perspective Therapeutics, Inc. (CATX), acquired 33,333 shares of common stock.
• The shares were purchased at a weighted average price of $2.2484.
• The price range for these shares was between $2.19 and $2.30.
• Following the transaction, Graham directly owns 35,354 shares of Perspective Therapeutics.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While the purchase of shares by the CFO is a positive sign, it's a relatively small transaction and doesn't provide a strong indication of future performance.

Positives

• The CFO's purchase of shares could be interpreted as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Insider transactions are closely monitored by investors as they can provide insights into management's perspective on the company's valuation and future performance. Purchases are generally seen as a positive sign.

Stakeholder Impact

• The purchase could have a slightly positive impact on shareholder sentiment.

Key Dates

Keywords

Perspective Therapeutics, CATX, Juan Graham, CFO, stock purchase, Form 4, insider trading